Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up For benign papilloma.

Slides:

Advertisements

Similar presentations

Pimp Session: Breast By James Lee, MD.

Advertisements

Alireza Mohammadzadeh, MD Thoracic Surgeon

WORK UPS. Ultrasound method of choice for the differentiation of cysts from solid masses and for guidance in interventional procedures. Benign: – solid.

Elsevier items and derived items © 2006 by Elsevier Inc. Assessment and Management of Patients With Breast Disorders.

Management of DCIS KWH Experience Dr. Carmen Ho.

Bloody Patient Presentation: A 42 year old white female came to the office complaining of painless bloody discharge from her left nipple which had occurred.

Leiomyosarcoma of the Vulva Bapir M, Hoh J & Al-Inizi S

Breast Diagnosis And Management of of Benign Breast Diseases Resident Basic Science Harry D. Bear, MD, PhD Division of Surgical Oncology Massey.

Breast Lump Bilateral Breast Exam No Palpable MassPalpable Mass Age < 35Age > 35 Diagnostic Mammogram -- unless negative mammogram within the past 6 months.

Surgical Oncology Surgical Oncology 05/13/12 – 05/19/2012 David Williams Andy Young Ashley Limkemann Yula Dzhashiashvili.

Interventions for Clients with Lung Cancer

Benign breast diseases Dr Maryam Tabatabaeian. Benign breast lesions  Non proliferative no risk for malignancy cysts,fcc without hyperplasia,epithalial.

Breast Tumors Diagnosed as Papillary Neoplasm by FNAB Dae-Kyum Kim, Sang-Uk Woo, Jeong-Han Kim, Seok-Jin Nam, Yoon-La Choi 1, Young-Lyun Oh 1 and Jung-Hyun.

Surgical Pathology Conference 一般外科 : CR 吳柏鋼 / VS. 張耀仁

BREAST CASES ARC 5, VI PAIRS MEETING HAMMAMET-TUNISIA 27 APRIL 2012 S.Mezghani- boussetta,S.Kechaou*, S.Melliti, M.Gadri, M.Chaabene* Ben Arous, Ariana*,

Pediatric Breast Mass Corey Johnson, MD R2 Seattle Children’s Hospital

Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology 57-year-old man with a painful tumoral mass in the leg.

OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.

6ème PAIRS-Hammamet-Tunis-avril2012

Dr. Amit Gupta Associate Professor Dept Of Surgery

Indications for Breast MR Imaging

Volume 39, Issue 4, Pages (July 2015)

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: Preoperative predictors of invasive breast cancer Ah Young.

Example 7: (A,B) Diagnostic mammogram in 63-year-old woman who presented with a palpable mass in the left breast. CC and MLO views of the left breast shows.

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Example 6: (A,B) Diagnostic mammography was obtained in this 70-year-old woman for a palpable mass in the right breast. There is a large speculated, irregular.

Fig. 2. Triple negative type breast cancer of 37-year-old woman. A

[P1]Can you put in the numbers here for specificity and NPV

Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.

Fig. 1. Preoperative mammography and breast ultrasound of a 60-year-old woman. A. Mammography reveals a 0.9 cm mass (arrows) with an indistinct margin.

Mammogram images (A, B) indicate an irregular mass in the upper outer left breast. Ultrasound of the left breast (C) shows this to be a solid, hypoechoic.

Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.

Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,

Current Status of Breast Ultrasound

اپیدمیولوژی شایع ترین سرطان در بین زنان ایرانی

Breast Ultrasound for the Interventionalist

Jeong Mi Park, MD, Limin Yang, MD, PhD, Archana Laroia, MD, Edmund A

Priscilla J. Slanetz, MD, MPH, FACR, Shieh-Pei Wu, MD, Jeffrey B

Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,

Priscilla J. Slanetz, MD, MPH, FACR, Shieh-Pei Wu, MD, Jeffrey B

Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial When using CT to screen.

CT Angiography of the Aorta: Contrast Timing by Using a Fixed versus a Patient-specific Trigger Delay In 108 participants undergoing CT angiography of.

Evaluation of a Flexible 12-Channel Screen-printed

In 507 follow-up images, only 1

The Potential Effect of Digital Breast Tomosynthesis on the Benign Biopsy Rate in Women Recalled within the UK Breast Screening Programme When compared.

Virtual noncontrast images yield high diagnostic performance (AUC 0

Neurodegeneration of the Substantia Nigra after Ipsilateral Infarct: MRI R2* Mapping and Relationship to Clinical Outcome Substantia nigra R2* was higher.

Local Tumor Staging of Breast Cancer: Digital Mammography versus Digital Mammography Plus Tomosynthesis Sensitivity was higher for combined digital mammography.

Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States Screening mammography performance metrics are.

Cost Effectiveness of Intraoperative MRI for Treatment of High-Grade Gliomas Compared with neuronavigation systems, intraoperative MRI reliably maximizes.

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular.

Reproducibility and Repeatability of MR Fingerprinting Relaxometry in the Human Brain Parameter values in solid brain tissues of healthy individuals measured.

Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular Subtypes Total external optoacoustic US feature scores of.

Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival Of 217 patients with lung cancer,

Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience After neoadjuvant.

Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes Following irreversible electroporation (IRE)

LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher.

ABUS = automated breast ultrasonography

Cystic changes within the endplates adjacent to the implants.

Management of Thyroid Nodules Seen on US Images: Deep Learning May Match Performance of Radiologists For discriminating malignant and benign nodules, deep.

Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer A.

Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening Trial.

Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI Using Revised 2017 International Consensus Guidelines.

Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer An imaging-based predictive model.

Iodine-based Dual-Energy CT of Traumatic Hemorrhagic Contusions: Relationship to In-Hospital Mortality and Short-term Outcome A B Quantitative.

Hyperpolarized Helium 3 MRI in Mild-to-Moderate Asthma: Prediction of Postbronchodilator Reversibility a b Helium 3 (3He) MRI ventilation defects at.

First Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies Bird S et al. Published Online: August.

Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.

Intraarticular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought? Adverse events after intraarticular corticosteroid (IACS)

Presentation transcript:

Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up For benign papilloma without atypia, the upgrade rate to malignancy was 1.9% after surgery, 2.1% after US-guided directional vacuum-assisted removal (DVAR), and 0% with US follow-up without intervention (P = .80) The recurrence rate after US-guided DVAR was 3.6%; all recurrences were confirmed as benign at surgery. In the group with US follow-up without intervention, 59 of the 61 lesions (97%) remained stable in size with no growth during a mean follow-up of 43.3 months; two lesions increased in size and were confirmed as benign at surgery. In a 42-year-old with bloody nipple discharge, A, mammography shows an oval mass (arrow). B, US shows a hypoechoic solid mass (arrows) with ductal dilatation. DVAR yielded a benign papilloma. Follow-up imaging showed no recurrence. A. B Choi HY et al. Published Online: August 20, 2019 https://doi.org/10.1148/radiol.2019190096 Choi HY et al. Published Online: August 20, 2019 https://doi.org/10.1148/radiol.2019190096